MYC and neoplasm: Taken together with the identification of EGFR and MYC amplification in cold tumours, our analysis suggests that pharmacological inhibition of EGFR/mTORC1/MYC-driven glycolysis could be an effective means by which to ‘warm-up’ these tumours and potentially enhance responses to ICB.